Acutus Medical Reports Second Quarter 2023 Financial Results
CARLSBAD, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the second quarter of 2023.
Related news for (AFIB)
- Acutus Medical Reports Full Year 2024 Financial Results
- Acutus Medical Announces Operational Downsizing
- Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results
- Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results
- Acutus Medical Reports First Quarter 2024 Financial Results